Lars Martinsen
Overview
Explore the profile of Lars Martinsen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
46
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Martinsen L, Osteras N, Moseng T, Tveter A
JMIR Rehabil Assist Technol
. 2024 Sep;
11:e54116.
PMID: 39283661
Background: Work burden increases for physiotherapists in the primary health care sector as the prevalence of musculoskeletal disorders (MSDs) increases. Digital health technologies (DHTs) are proposed as a viable solution...
2.
Buhl S, Steenholdt C, Brynskov J, Christensen K, Dorn-Rasmussen M, Thomsen O, et al.
NEJM Evid
. 2024 Feb;
1(8):EVIDoa2200061.
PMID: 38319804
BACKGROUND: Whether infliximab therapy can be successfully discontinued after patients with Crohn’s disease have attained sustained, clinical, biochemical, and endoscopic remission is unknown. METHODS: We conducted a multicenter, randomized, double-blind,...
3.
Martinsen L, Osteras N, Moseng T, Tveter A
BMJ Open
. 2022 Sep;
12(9):e066248.
PMID: 36153027
Introduction: Soaring prevalence of hip and knee osteoarthritis (OA) inflicts high costs on the healthcare system. A further rise in the OA incidence is expected, generating increased demand of care...
4.
Pedersen N, Thielsen P, Martinsen L, Bennedsen M, Haaber A, Langholz E, et al.
Inflamm Bowel Dis
. 2014 Sep;
20(12):2276-85.
PMID: 25248002
Background: To individualize treatment with mesalazine for ulcerative colitis relapses through a self-managed, web-based solution to optimize the short-term disease course. Methods: Prospective, open-label, web-guided study with 3 months mesalazine...